G C-L Chi, F-S Hsu, C-C Yang, J C-C Wei. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AlefaceptAntirheumatic Agents/therapeutic useFemaleHumansMiddle AgedRecombinant Fusion Proteins/therapeutic useScleroderma, Systemic/drug therapyTreatment Failure
Substances： See more » Antirheumatic AgentsRecombinant Fusion ProteinsAlefacept
Year: 2005 PMID： 15972344 DOI： 10.1093/rheumatology/kei017
Source DB: PubMed Journal: Rheumatology (Oxford) ISSN： 1462-0324 Impact factor: 7.580